The Medicare GLP-1 Bridge is a short-term demonstration run by CMS that will provide eligible Medicare Part D beneficiaries with access to certain GLP-1 drugs between July 1, 2026, and December 31, 2027.
The Medicare GLP-1 Bridge will operate outside of the Medicare Part D benefit’s coverage and payment flow. As a result, Part D sponsors will not carry risk for eligible GLP-1 drugs furnished under the Medicare GLP-1 Bridge, and Part D sponsors do not have to opt in to the Medicare GLP-1 Bridge for eligible beneficiaries to access these drugs beginning July 1, 2026. In 2026, CMS will use a single central processor to manage prior authorization, claims adjudication, and payment to pharmacies for the Medicare GLP-1 Bridge.
People with Medicare can learn about Medicare GLP-1 Bridge and check if they might qualify at Medicare.gov/glp1bridge. They can also call 1-800-MEDICARE (1-800-633-4227) with questions or to get more information. TTY users can call 1-877-486-2048.
SOURCE: Medicare GLP-1 Bridge | CMS